References
- Abbas S, Nieters A, Linseisen J, et al (2008). Vitamin D receptor gene polymorphisms and haplotypes and postmenopausal breast cancer risk. Breast Cancer Res, 10, R31. https://doi.org/10.1186/bcr1994
- Anderson LN, Cotterchio M, Cole DE, Knight JA (2011). Vitamin D-related genetic variants, interactions with vitamin D exposure, and breast cancer risk among Caucasian women in Ontario. Cancer Epidemiol Biomarkers Prev, 20, 1708-17. https://doi.org/10.1158/1055-9965.EPI-11-0300
- Bretherton-Watt D, Given-Wilson R, Mansi JL, et al (2001). Vitamin D receptor gene polymorphisms are associated with breast cancer risk in a UK Caucasian population. Br J Cancer, 85, 171-5. https://doi.org/10.1054/bjoc.2001.1864
- Buyru N, Tezol A, Yosunkaya-Fenerci E, Dalay N (2003). Vitamin D receptor gene polymorphisms in breast cancer. Exp Mol Med, 35, 550-5. https://doi.org/10.1038/emm.2003.72
- Chakraborty A, Mishra AK, Soni A, et al (2009). Vitamin D receptor gene polymorphism(s) and breast cancer risk in north Indians. Cancer Detect Prev, 32, 386-94. https://doi.org/10.1016/j.canep.2009.04.012
- Chen WY, Bertone-Johnson ER, Hunter DJ, et al (2005). Associations between polymorphisms in the vitamin D receptor and breast cancer risk. Cancer Epidemiol Biomarkers Prev, 14, 2335-9. https://doi.org/10.1158/1055-9965.EPI-05-0283
- Cui J, Shen K, Shen Z, et al (2001). [Relationship of vitamin D receptor polymorphism with breast cancer]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 18, 286-8.
- Curran JE, Vaughan T, Lea RA, et al (1999). Association of A vitamin D receptor polymorphism with sporadic breast cancer development. Int J Cancer, 83, 723-6. https://doi.org/10.1002/(SICI)1097-0215(19991210)83:6<723::AID-IJC4>3.0.CO;2-3
- Dalessandri KM, Miike R, Wiencke JK, et al (2012). Vitamin D receptor polymorphisms and breast cancer risk in a highincidence population: a pilot study. J Am Coll Surg, 215, 652-7. https://doi.org/10.1016/j.jamcollsurg.2012.06.413
- Dunning AM, McBride S, Gregory J, et al (1999). No association between androgen or vitamin D receptor gene polymorphisms and risk of breast cancer. Carcinogenesis, 20, 2131-5. https://doi.org/10.1093/carcin/20.11.2131
- Duval S, Tweedie R (2000). Trim and fill: A simple funnel-plotbased method of testing and adjusting for publication bias in meta-analysis. Biometrics, 56, 455-63. https://doi.org/10.1111/j.0006-341X.2000.00455.x
- Engel LS, Orlow I, Sima CS, et al (2012). Vitamin D receptor gene haplotypes and polymorphisms and risk of breast cancer: a nested case-control study. Cancer Epidemiol Biomarkers Prev, 21, 1856-67. https://doi.org/10.1158/1055-9965.EPI-12-0551
- Fuhrman BJ, Freedman DM, Bhatti P, et al (2013). Sunlight, polymorphisms of vitamin D-related genes and risk of breast cancer. Anticancer Res, 33, 543-51.
- Gapska P, Scott RJ, Serrano-Fernandez P, et al (2009). Vitamin D receptor variants and breast cancer risk in the Polish population. Breast Cancer Res Treat, 115, 629-33. https://doi.org/10.1007/s10549-008-0107-1
- Guy M, Lowe LC, Bretherton-Watt D, et al (2004). Vitamin D receptor gene polymorphisms and breast cancer risk. Clin Cancer Res, 10, 5472-81. https://doi.org/10.1158/1078-0432.CCR-04-0206
- Hefler LA, Tempfer CB, Grimm C, et al (2004). Estrogenmetabolizing gene polymorphisms in the assessment of breast carcinoma risk and fibroadenoma risk in Caucasian women. Cancer, 101, 264-9. https://doi.org/10.1002/cncr.20361
- Hou MF, Tien YC, Lin GT, et al (2002). Association of vitamin D receptor gene polymorphism with sporadic breast cancer in Taiwanese patients. Breast Cancer Res Treat, 74, 1-7. https://doi.org/10.1023/A:1016048900049
- Huang J, Huang J, Ma Y, et al (2013). The Cdx-2 polymorphism in the VDR gene is associated with increased risk of cancer: a meta-analysis. Mol Biol Rep, 40, 4219-25. https://doi.org/10.1007/s11033-013-2503-9
- Huang J, Yang J, Wang H, et al (2013). The association between the poly(A) polymorphism in the VDR gene and cancer risk: a meta-analysis. Tumour Biol, 34, 1833-8. https://doi.org/10.1007/s13277-013-0724-0
- Ingles SA, Garcia DG, Wang W, et al (2000). Vitamin D receptor genotype and breast cancer in Latinas (United States). Cancer Causes Control, 11, 25-30. https://doi.org/10.1023/A:1008979417618
- John EM, Schwartz GG, Koo J, et al (2007). Sun exposure, vitamin D receptor gene polymorphisms, and breast cancer risk in a multiethnic population. Am J Epidemiol, 166, 1409-19. https://doi.org/10.1093/aje/kwm259
- Lau J, Ioannidis JP, Schmid CH (1997). Quantitative synthesis in systematic reviews. Ann Intern Med, 127, 820-6. https://doi.org/10.7326/0003-4819-127-9-199711010-00008
- Lopes N, Sousa B, Martins D, et al (2010). Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions. BMC Cancer, 10, 483. https://doi.org/10.1186/1471-2407-10-483
- Lowe LC, Guy M, Mansi JL, et al (2005). Plasma 25-hydroxy vitamin D concentrations, vitamin D receptor genotype and breast cancer risk in a UK Caucasian population. Eur J Cancer, 41, 1164-9. https://doi.org/10.1016/j.ejca.2005.01.017
- Lundin AC, Soderkvist P, Eriksson B, et al (1999). Association of breast cancer progression with a vitamin D receptor gene polymorphism. South-East Sweden Breast Cancer Group. Cancer Res, 59, 2332-4.
- McCullough ML, Bostick RM, Mayo TL (2009). Vitamin D gene pathway polymorphisms and risk of colorectal, breast, and prostate cancer. Annu Rev Nutr, 29, 111-32. https://doi.org/10.1146/annurev-nutr-080508-141248
- McCullough ML, Stevens VL, Diver WR, et al (2007). Vitamin D pathway gene polymorphisms, diet, and risk of postmenopausal breast cancer: a nested case-control study. Breast Cancer Res, 9, R9. https://doi.org/10.1186/bcr1642
- McKay JD, McCullough ML, Ziegler RG, et al (2009). Vitamin D receptor polymorphisms and breast cancer risk: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. Cancer Epidemiol Biomarkers Prev, 18, 297-305. https://doi.org/10.1158/1055-9965.EPI-08-0539
- Mishra DK, Wu Y, Sarkissyan M, et al (2013). Vitamin D receptor gene polymorphisms and prognosis of breast cancer among African-American and Hispanic women. PLoS One, 8, e57967. https://doi.org/10.1371/journal.pone.0057967
- Newcomb PA, Kim H, Trentham-Dietz A, et al (2002). Vitamin D receptor polymorphism and breast cancer risk. Cancer Epidemiol Biomarkers Prev, 11, 1503-4.
- Rollison DE, Cole AL, Tung KH, et al (2012). Vitamin D intake, vitamin D receptor polymorphisms, and breast cancer risk among women living in the southwestern U.S. Breast Cancer Res Treat, 132, 683-91. https://doi.org/10.1007/s10549-011-1885-4
- Shab-Bidar S, Neyestani TR, Djazayery A (2011). Efficacy of vitamin D3-fortified-yogurt drink on anthropometric, metabolic, inflammatory and oxidative stress biomarkers according to vitamin D receptor gene polymorphisms in type 2 diabetic patients: a study protocol for a randomized controlled clinical trial. BMC Endocr Disord, 11, 12. https://doi.org/10.1186/1472-6823-11-12
- Shahbazi S, Alavi S, Majidzadeh-A K, et al (2013). BsmI but not FokI polymorphism of VDR gene is contributed in breast cancer. Med Oncol, 30, 393. https://doi.org/10.1007/s12032-012-0393-7
- Sillanpaa P, Hirvonen A, Kataja V, et al (2004). Vitamin D receptor gene polymorphism as an important modifier of positive family history related breast cancer risk. Pharmacogenetics, 14, 239-45. https://doi.org/10.1097/00008571-200404000-00003
- Sinotte M, Rousseau F, Ayotte P, et al (2008). Vitamin D receptor polymorphisms (FokI, BsmI) and breast cancer risk: association replication in two case-control studies within French Canadian population. Endocr Relat Cancer, 15, 975-83. https://doi.org/10.1677/ERC-08-0056
- Tang C, Chen N, Wu M, et al (2009). Fok1 polymorphism of vitamin D receptor gene contributes to breast cancer susceptibility: a meta-analysis. Breast Cancer Res Treat, 117, 391-9. https://doi.org/10.1007/s10549-008-0262-4
- Trabert B, Malone KE, Daling JR, et al (2007). Vitamin D receptor polymorphisms and breast cancer risk in a large population-based case-control study of Caucasian and African-American women. Breast Cancer Res, 9, R84. https://doi.org/10.1186/bcr1833
- VandeVord PJ, Wooley PH, Darga LL, et al (2006). Genetic determinants of bone mass do not relate with breast cancer risk in US white and African-American women. Breast Cancer Res Treat, 100, 103-7. https://doi.org/10.1007/s10549-006-9228-6
- Wang H, Wang W, Yang D, Wang S (2013). TaqI polymorphism of VDR gene contributes to breast cancer risk. Tumour Biol, doi:10.1007/s13277-013-1011-9.
- Wang J, He Q, Shao YG, et al (2013). Associations between vitamin D receptor polymorphisms and breast cancer risk. Tumour Biol, doi:10.1007/s13277-013-0967-9.
- Wedren S, Magnusson C, Humphreys K, et al (2007). Associations between androgen and Vitamin D receptor microsatellites and postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev, 16, 1775-83. https://doi.org/10.1158/1055-9965.EPI-06-1096
- Wells GA, Shea B, O'Connell D, et al (2011). The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. [cited 28 August 2013]. Available from http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
- Yao S, Zirpoli G, Bovbjerg DH, et al (2012). Variants in the vitamin D pathway, serum levels of vitamin D, and estrogen receptor negative breast cancer among African-American women: a case-control study. Breast Cancer Res, 14, R58. https://doi.org/10.1186/bcr3162
- Zhou ZC, Wang J, Cai ZH, et al (2013). Association between vitamin D receptor gene Cdx2 polymorphism and breast cancer susceptibility. Tumour Biol, doi:10.1007/s13277-013-0919-4.
Cited by
- Role of Vitamin D Deficiency and Lack of Sun Exposure in the Incidence of Premenopausal Breast Cancer: a Case Control Study in Sabzevar, Iran vol.15, pp.8, 2014, https://doi.org/10.7314/APJCP.2014.15.8.3391
- Cdx2 Polymorphism Affects the Activities of Vitamin D Receptor in Human Breast Cancer Cell Lines and Human Breast Carcinomas vol.10, pp.4, 2015, https://doi.org/10.1371/journal.pone.0124894
- Role of vitamin D receptor gene Cdx2 and Apa1 polymorphisms in prostate cancer susceptibility: a meta-analysis vol.16, pp.1, 2016, https://doi.org/10.1186/s12885-016-2722-2
- Polymorphisms of Genes Related to Function and Metabolism of Vitamin D in Esophageal Adenocarcinoma pp.1941-6636, 2018, https://doi.org/10.1007/s12029-018-0164-6